Kaushik-Basu N - Search Results

1

Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors.

Musmuca I, Caroli A, Mai A, Kaushik-Basu N, Arora P, Ragno R. Musmuca I, et al. J Chem Inf Model. 2010 Apr 26;50(4):662-76. doi: 10.1021/ci9004749. J Chem Inf Model. 2010. PMID: 20225870

2

Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.

Talele TT, Arora P, Kulkarni SS, Patel MR, Singh S, Chudayeu M, Kaushik-Basu N. Talele TT, et al. Bioorg Med Chem. 2010 Jul 1;18(13):4630-8. doi: 10.1016/j.bmc.2010.05.030. Epub 2010 May 15. Bioorg Med Chem. 2010. PMID: 20627595 Free PMC article.

3

Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.

Nichols DB, Fournet G, Gurukumar KR, Basu A, Lee JC, Sakamoto N, Kozielski F, Musmuca I, Joseph B, Ragno R, Kaushik-Basu N. Nichols DB, et al. Eur J Med Chem. 2012 Mar;49:191-9. doi: 10.1016/j.ejmech.2012.01.010. Epub 2012 Jan 12. Eur J Med Chem. 2012. PMID: 22280819 Free PMC article.

4

Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.

Rawal RK, Katti SB, Kaushik-Basu N, Arora P, Pan Z. Rawal RK, et al. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6110-4. doi: 10.1016/j.bmcl.2008.10.023. Epub 2008 Oct 8. Bioorg Med Chem Lett. 2008. PMID: 18947995 Free PMC article.

5

Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.

Çıkla-Süzgün P, Kaushik-Basu N, Basu A, Arora P, Talele TT, Durmaz I, Çetin-Atalay R, Küçükgüzel ŞG. Çıkla-Süzgün P, et al. Among authors: kaushik basu n. J Enzyme Inhib Med Chem. 2015;30(5):778-85. doi: 10.3109/14756366.2014.971780. J Enzyme Inhib Med Chem. 2015. PMID: 25676325 Free article.

6

3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.

Patel PD, Patel MR, Kaushik-Basu N, Talele TT. Patel PD, et al. J Chem Inf Model. 2008 Jan;48(1):42-55. doi: 10.1021/ci700266z. Epub 2007 Dec 13. J Chem Inf Model. 2008. PMID: 18076152

7

Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor.

Chen Y, Bopda-Waffo A, Basu A, Krishnan R, Silberstein E, Taylor DR, Talele TT, Arora P, Kaushik-Basu N. Chen Y, et al. Antivir Chem Chemother. 2009 Sep 25;20(1):19-36. doi: 10.3851/IMP1286. Antivir Chem Chemother. 2009. PMID: 19794229 Free article.

8

Design and synthesis of L- and D-phenylalanine derived rhodanines with novel C5-arylidenes as inhibitors of HCV NS5B polymerase.

Patel BA, Krishnan R, Khadtare N, Gurukumar KR, Basu A, Arora P, Bhatt A, Patel MR, Dana D, Kumar S, Kaushik-Basu N, Talele TT. Patel BA, et al. Bioorg Med Chem. 2013 Jun 1;21(11):3262-71. doi: 10.1016/j.bmc.2013.03.041. Epub 2013 Mar 31. Bioorg Med Chem. 2013. PMID: 23598249 Free PMC article.

9

Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.

Therese PJ, Manvar D, Kondepudi S, Battu MB, Sriram D, Basu A, Yogeeswari P, Kaushik-Basu N. Therese PJ, et al. J Chem Inf Model. 2014 Feb 24;54(2):539-52. doi: 10.1021/ci400644r. Epub 2014 Feb 5. J Chem Inf Model. 2014. PMID: 24460140

10

Etodolac Thiosemicarbazides: A novel class of hepatitis C virus NS5B polymerase inhibitors.

Çıkla P, Arora P, Basu A, Talele TT, Kaushik-Basu N, Küçükgüzel ŞG. Çıkla P, et al. Marmara Pharm J. 2013;17:138-146. Marmara Pharm J. 2013. PMID: 30948924 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters